Nidek's hyperopia algorithm tops FDA criteria

Fremont, CA-The FDA has given the go-ahead to an expansion of Nidek Inc.'s hyperopia study using new software for its U.S. EC-5000 platform.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.